Sophie Jamal
Sophie Jamal
| Nationality | Canadian |
|---|---|
| Known for | Research in osteoporosis and bone health |
Sophie Jamal is a Canadian endocrinologist and researcher known for her work in the field of osteoporosis and bone health. She has held prominent positions at the University of Toronto and Women's College Hospital.
Early Life and Education[edit | edit source]
Sophie Jamal was born in Canada and pursued her undergraduate studies at McGill University, where she developed an interest in medicine and research. She later attended the University of Toronto for her medical degree, where she specialized in endocrinology.
Career[edit | edit source]
Jamal began her career as a clinician and researcher at Women's College Hospital, where she focused on osteoporosis, a condition characterized by weakened bones and an increased risk of fractures. Her research aimed to improve the understanding of bone density and the factors that contribute to bone health.
Research Contributions[edit | edit source]
Jamal's research has significantly contributed to the field of osteoporosis. She has published numerous studies on the effects of various treatments on bone density and fracture risk. Her work has been recognized for its impact on clinical practices and guidelines for managing osteoporosis.
Controversies[edit | edit source]
In 2015, Sophie Jamal was involved in a controversy regarding the integrity of her research data. An investigation revealed that some of her studies contained falsified data, leading to retractions of several published papers. This incident highlighted the importance of research ethics and the need for rigorous data verification processes in scientific research.
Awards and Recognition[edit | edit source]
Despite the controversies, Jamal has been recognized for her contributions to medical research and education. She has received several awards for her work in endocrinology and osteoporosis.
Personal Life[edit | edit source]
Sophie Jamal is known for her dedication to her patients and her passion for teaching medical students. She continues to be involved in medical education and advocacy for bone health.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
